Kura Oncology Inc (KURA)
8.93
-0.08
(-0.89%)
USD |
NASDAQ |
Dec 23, 16:00
8.93
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Cash from Investing (Quarterly): 45.54M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | -167.48M |
| AIM ImmunoTech Inc | 0.334M |
| Perspective Therapeutics Inc | -29.74M |
| Protalix BioTherapeutics Inc | 20.33M |
| Armata Pharmaceuticals Inc | -0.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -43.44M |
| Cash from Financing (Quarterly) | 2.202M |
| Free Cash Flow | -169.24M |
| Free Cash Flow Per Share (Quarterly) | -0.4996 |
| Free Cash Flow Yield | -22.64% |